Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Johnson Laura L.
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FAVORITO TAMARA A
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hoffman Robert E.
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director TOTH ROBERT JOSEPH JR
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brown Dennis M
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hoffman Robert E.
Kintara Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0.1%),Lind Global Partners II LLC(0.1%), etc.
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.8%),Lind Global Partners II LLC(5.8%), etc.
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Carolyn A. Pilkiewicz(2.41%),Michael B. DeGidio(2.38%), etc.
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities
No Data